Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Focal Segmental Nephrosis”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Not applicableNot Yet RecruitingNCT07010250
What this trial is testing

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

Who this might be right for
ANCA Associated VasculitisExtramembranous GlomerulopathyNephrotic Syndrome, Minimal Change+4 more
Assistance Publique - Hôpitaux de Paris 146
Testing effectiveness (Phase 2)Study completedNCT03422510
What this trial is testing

FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Primary Focal Segmental Glomerulosclerosis
Complexa, Inc. 33
Not applicableLooking for participantsNCT04571658
What this trial is testing

NEPTUNE Match Study

Who this might be right for
Nephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more
University of Michigan 375
Not applicableActive Not RecruitingNCT02194582
What this trial is testing

Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure

Who this might be right for
Focal Segmental GlomerulosclerosisNephrotic SyndromeEnd Stage Renal Disease+2 more
Beth Israel Deaconess Medical Center 2,050
Testing effectiveness (Phase 2)Ended earlyNCT04950114
What this trial is testing

An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

Who this might be right for
Kidney DiseasesGlomerulosclerosisFocal Segmental Nephrosis+4 more
Goldfinch Bio, Inc. 31
Large-scale testing (Phase 3)Study completedNCT00981838
What this trial is testing

Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Nephrotic Syndrome
Mario Negri Institute for Pharmacological Research 24
Not applicableLooking for participantsNCT06334692
What this trial is testing

Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Mario Negri Institute for Pharmacological Research 100
Testing effectiveness (Phase 2)Study completedNCT02592798
What this trial is testing

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

Who this might be right for
Nephrotic SyndromeFocal Segmental GlomerulosclerosisMinimal Change Disease
Bristol-Myers Squibb 36
Testing effectiveness (Phase 2)Ended earlyNCT04387448
What this trial is testing

TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease

Who this might be right for
Kidney DiseasesDiabetic NephropathiesGlomerulosclerosis, Focal Segmental+8 more
Goldfinch Bio, Inc. 96
Testing effectiveness (Phase 2)Study completedNCT00098020
What this trial is testing

Podocyte Retinoids

Who this might be right for
Collapsing GlomerulopathyGlomerulosclerosis, Focal Segmental
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12
Not applicableUnknownNCT04174066
What this trial is testing

From Immune System Damage to Podocyte Cell Damage: Prospective Database and Biological Collection of Patients (Children and Adults) With MGLS and HSFP

Who this might be right for
Nephrotic Syndrome
Centre Hospitalier Universitaire de Nice 144
Early research (Phase 1)Study completedNCT03970122
What this trial is testing

FIH Ph 1 Study of TRPC5 Channel Inhibitor GFB-887 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Goldfinch Bio, Inc. 70
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Early research (Phase 1)UnknownNCT02382874
What this trial is testing

Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis)

Who this might be right for
Focal Segmental Glomerulosclerosis
Royan Institute 5
Not applicableLooking for participantsNCT05650619
What this trial is testing

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseFSGS+1 more
University of Michigan 300
Not applicableEnded earlyNCT00883636
What this trial is testing

Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental GlomerulosclerosisNephrotic SyndromeSteroid Resistant Nephrotic Syndrome+1 more
Northwell Health 4
Testing effectiveness (Phase 2)Study completedNCT02000440
What this trial is testing

A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Glomerulosclerosis, Focal Segmental
GlaxoSmithKline 17
Testing effectiveness (Phase 2)Looking for participantsNCT06500702
What this trial is testing

Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion
Sanofi 84
Testing effectiveness (Phase 2)Study completedNCT00004990
What this trial is testing

Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis

Who this might be right for
GlomerulonephritisNephrotic Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 20
Not applicableEnded earlyNCT04235621
What this trial is testing

Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Who this might be right for
Glomerulosclerosis, Focal SegmentalMinimal Change DiseaseDiabetic Nephropathies
Goldfinch Bio, Inc. 20
Load More Results